Evidence map›Paper›PMID 29973907›Full record

ArticleFrontiers in neurology2018

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease.

Anna-Maija Penttinen, Ilmari Parkkinen, Merja H Voutilainen, Maryna Koskela, Susanne Bäck, Anna Their, Christopher T Richie, Andrii Domanskyi, Brandon K Harvey, Raimo K Tuominen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Neurotrophin Regulation and Signaling in Airway Smooth Muscle.Advances in experimental medicine and biology · 2021
    Article
  7. Review
  8. Article
  9. Neuronal Activation Stimulates Cytomegalovirus Promoter-Driven Transgene Expression.Molecular therapy. Methods & clinical development · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Anna-Maija PenttinenHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Ilmari ParkkinenHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Merja H VoutilainenHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Maryna KoskelaHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Susanne BäckDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Anna TheirHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Christopher T RichieNational Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States.
Andrii DomanskyiHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Brandon K HarveyNational Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States.
Raimo K TuominenDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Liina NevalaitaHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Mart SaarmaHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Mikko AiravaaraHiLIFE Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
University of Helsinki · FINational Institute on Drug Abuse · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is one of the most studied neurotrophic factors. GDNF has two splice isoforms, full-length pre-α-pro-GDNF (α-GDNF) and pre-β-pro-GDNF (β-GDNF), which has a 26 amino acid deletion in the pro-region. Thus far, studies have focused solely on the α-GDNF isoform, and nothing is known about the

Indexed as

alternative splicingdopamineGDNFneurodegenerationneurotrophic factorssplice varianttyrosine hydroxylase

Identifiers

PMID29973907
PMCPMC6019446
OpenAlexW2807458946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.